May 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2018 Mar 31, 2017 Mar 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 17.89 16.14 19.40
(+10.8 pct) (+8.9 pct) (+8.5 pct)
Operating 2.40 1.77 2.52
(+35.6 pct) (+16.0 pct) (+5.0 pct)
Recurring 2.39 1.75 2.50
(+36.7 pct) (+13.7 pct) (+4.6 pct)
Net
Net 1.60 1.21 1.69
(+31.7 pct) (+23.5 pct) (+5.8 pct)
EPS 406.20 yen 308.52 yen 429.63 yen
Ann Div 30.00 yen 30.00 yen 30.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 30.00 yen 30.00 yen 30.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T